Insiders Cullinan Therapeutics, Inc.

Equities

CGEM

US2300311063

Delayed Nasdaq Other stock markets 01:00:00 2024-07-03 pm EDT			5-day change	1st Jan Change
16.78 ^USD	+2.88%		+1.70%	+64.67%

Jul. 01	Cullinan Therapeutics, Inc.(NasdaqGS:CGEM) added to Russell Small Cap Comp Growth Index	CI
Jun. 02	Transcript : Cullinan Therapeutics, Inc. - Special Call

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cullinan Therapeutics, Inc. Announces Board Changes	May. 15	CI
Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing	May. 09	MT
Cullinan Therapeutics Appoints Mary Kay Fenton as CFO	Apr. 29	MT
Cullinan Oncology Finance Chief Jeffrey Trigilio to Leave	Mar. 14	MT
Cullinan Oncology Insider Sold Shares Worth $647,200, According to a Recent SEC Filing	Feb. 05	MT
Cullinan Oncology Insider Sold Shares Worth $563,600, According to a Recent SEC Filing	Jan. 31	MT
Cullinan Oncology, Inc. Announces Transition of Patrick Baeuerle from Chief Scientific Officer of the Company to Co-Founder, Chief Scientific Advisor, Chair of Scientific Advisory Board	23-06-14	CI
Insider Sell: Cullinan Oncology	23-06-08	MT
Ikena Oncology Appoints Owen Hughes Board Chairman	22-12-20	MT
Cullinan Oncology Appoints of David P. Ryan to Its Board of Directors	22-11-02	CI
Cullinan Oncology, Inc. Appoints Jacquelyn Sumer as Chief Legal Officer	22-08-15	CI
Insider Sell: Cullinan Oncology	22-07-26	MT
Insider Sell: Cullinan Oncology	22-07-21	MT
Insider Buy: Cullinan Oncology	22-06-07	MT
Cullinan Oncology, Inc. Announces Management Appointments	22-02-28	CI
Cullinan Oncology, Inc. Announces the Resignation of Morana Jovan-Embiricos as Director Effective as of December 31, 2021	21-12-29	CI
Insider Sell: Cullinan Oncology	21-10-18	MT
Cullinan Oncology, Inc. Appoints Nadim Ahmed as President and Member of Board of Directors	21-10-18	CI
Consolidated Gems : Cullinan Oncology Names Nadim Ahmed Chief Executive Officer	21-10-18	MT
Cullinan Oncology, Inc. Announces Executive Changes	21-10-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cullinan Therapeutics, Inc.

Equities

CGEM

US2300311063

Insiders

Filters